medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2020, Number 1

<< Back Next >>

Rev Mex Urol 2020; 80 (1)

Risk factors for urinary tract infection after midurethral sling placement

Zapico OCA, Rodríguez CS, Ramírez IC, Gorbea CV, Granados MV

Language: Spanish
References: 13
Page: 1-9
PDF size: 172.12 Kb.


ABSTRACT

Background: Urinary tract infection (UTI) is one of the most common bacterial infections in women. UTI rates after midurethral sling (MUS) placement are as high as 34% within the first 3 postoperative months and can reach 50% at one year. The aim of the present study was to determine the frequency of UTI and its recurrence at one year from MUS placement and to identify the risk factors.
Materials and methods: A case-control study was conducted on patients that underwent MUS placement within the time frame of 2014-2017 and completed one postoperative year. They were divided into two groups: the cases that presented with UTI and the controls that did not. All variables were expressed through descriptive statistics and the two groups were compared. Odds ratio (OR) was calculated and risk adjustment was performed on the statistically significant variables. The SPSS version 25 program was employed for the statistical analysis and statistical significance was set at a p‹0.05.
Results: The study was carried out on 267 patients. Thirty-four patients (12.7%) presented with UTI and 9 patients (3.4%) presented with recurrent UTI. A total of 250 TOT slings (93.6%) were placed and 17 TVT slings (6.4%). Six patients with TVT slings (35.2%) and 28 with TOT slings (11.2%) presented with UTI during the first postoperative year, with a statistically significant association. Regarding the risk factors, TVT sling placement produced an OR of 4.32 (95%CI=1.48-12.6) and the use of a urinary catheter for more than 48 hours resulted in an OR of 8.40 (95%CI=3.23-21.8).
Conclusions: The frequency of UTI and recurrent UTI after MUS placement was similar to that reported in the literature. We found TVT sling placement and the use of a urinary catheter › 48 hours to be risk factors for UTI.


REFERENCES

  1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113(1):5–13. doi: 10.1016/S0002-9343(02)01054-9

  2. Guglietta A. Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis. Future Microbiology. 2017;12(3):239–46. doi: 10.2217/fmb-2016-0145

  3. Nosseir SB, Lind LR, Winkler HA. Recurrent uncomplicated urinary tract infections in women: a review. J Womens Health (Larchmt). 2012;21(3):347–54. doi: 10.1089/ jwh.2011.3056

  4. Imamura M, Hudson J, Wallace SA, MacLennan G, Shimonovich M, Omar MI, et al. Surgical interventions for women with stress urinary incontinence: systematic review and network meta-analysis of randomised controlled trials. BMJ. 2019;365: l1842. doi: 10.1136/bmj.l1842

  5. Schimpf MO, Rahn DD, Wheeler TL, Patel M, White AB, Orejuela FJ, et al. Sling surgery for stress urinary incontinence in women: a systematic review and metaanalysis. Am J Obstet Gynecol. 2014;211(1):71.e1-71.e27. doi: 10.1016/j.ajog.2014.01.030

  6. Nygaard I, Brubaker L, Chai TC, Markland AD, Menefee SA, Sirls L, et al. Risk factors for urinary tract infection following incontinence surgery. Int Urogynecol J. 2011;22(10):1255– 65. doi: 10.1007/s00192-011-1429-9

  7. Weintraub AY, Reuven Y, Paz-Levy D, Yohay Z, Idan I, Elharar D, et al. Prevalence and risk factors for urinary tract infection up to one year following midurethral sling incontinence surgery. Eur J Obstet Gynecol Reprod Biol. 2018; 222:146–50. doi: 10.1016/j.ejogrb.2018.01.028

  8. Anger JT, Litwin MS, Wang Q, Pashos CL, Rodríguez LV. Complications of sling surgery among female Medicare beneficiaries. Obstet Gynecol. 2007;109(3):707–14. doi: 10.1097/01. AOG.0000255975.24668.f2

  9. Suskind AM, Clemens JQ, Dunn RL, Zhang Y, Stoffel JT, Hollenbeck BK. Effectiveness of mesh compared with nonmesh sling surgery in Medicare beneficiaries. Obstet Gynecol. 2013;122(3):546–52. doi: 10.1097/ AOG.0b013e31829e8543

  10. Jackson D, Higgins E, Bracken J, Yandell PM, Shull B, Foster RT. Antibiotic prophylaxis for urinary tract infection after midurethral sling: a randomized controlled trial. Female Pelvic Med Reconstr Surg. 2013;19(3):137–41. doi: 10.1097/SPV.0b013e318285ba53

  11. Groutz A, Levin I, Gold R, Pauzner D, Lessing JB, Gordon D. ‘Inside-out’ transobturator tension-free vaginal tape for management of occult stress urinary incontinence in women undergoing pelvic organ prolapse repair. Urology. 2010;76(6):1358–61. doi: 10.1016/j. urology.2010.04.070

  12. Hammett J, Lukman R, Oakes M, Whitcomb EL. Recurrent Urinary Tract Infection After Midurethral Sling: A Retrospective Study. Female Pelvic Med Reconstr Surg. 2016;22(6):438–41. doi: 10.1097/SPV.0000000000000308

  13. Vigil HR, Mallick R, Nitti VW, Lavallée LT, Breau RH, Hickling DR. Risk Factors for Urinary Tract Infection following Mid Urethral Sling Surgery. J Urol. 2017;197(5):1268–73. doi: 10.1016/j.juro.2016.12.093




2020     |     www.medigraphic.com